Cardiff Lexington Corp financial data

Symbol
CDIX on OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
Location
3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV
State of incorporation
FL
Fiscal year end
December 31
Former names
CARDIFF INTERNATIONAL INC (to 1/26/2018)
Latest financial report
10-K - Q4 2024 - Mar 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 114 % +25.3%
Debt-to-equity 451 %
Return On Equity -97.8 % +86.3%
Return On Assets -13.9 % -180%
Operating Margin -2.34 % -105%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.3M shares +76.9%
Common Stock, Shares, Outstanding 15.3M shares
Entity Public Float 81.2M USD
Common Stock, Value, Issued 15.3K USD
Weighted Average Number of Shares Outstanding, Basic 11.4M shares
Weighted Average Number of Shares Outstanding, Diluted 11.4M shares

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8.27M USD -30.2%
Cost of Revenue 3.84M USD +7.89%
Operating Income (Loss) -194K USD -104%
Nonoperating Income (Expense) -3M USD -44.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.19M USD -202%
Net Income (Loss) Attributable to Parent -3.3M USD -209%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 15.9M USD +19.8%
Assets, Current 17.2M USD +21.4%
Property, Plant and Equipment, Net 21.2K USD -38.8%
Operating Lease, Right-of-Use Asset 407K USD +40.8%
Goodwill 5.67M USD 0%
Assets 23.9M USD +15.3%
Accounts Payable, Current 684K USD -5.06%
Liabilities, Current 15.9M USD +14.6%
Operating Lease, Liability, Noncurrent 186K USD +56.1%
Liabilities 16.3M USD +15.6%
Retained Earnings (Accumulated Deficit) -72.9M USD -6.21%
Stockholders' Equity Attributable to Parent 2.69M USD +267%
Liabilities and Equity 23.9M USD +15.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Financing Activities 313K USD +4.24%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 15.3M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.19M USD +37.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50K USD +3227%
Deferred Tax Assets, Valuation Allowance 5.9M USD +11.5%
Deferred Tax Assets, Gross 5.9M USD +11.5%
Operating Lease, Liability 409K USD
Depreciation 13.5K USD -35.2%
Lessee, Operating Lease, Liability, to be Paid 438K USD +58.4%
Property, Plant and Equipment, Gross 137K USD 0%
Operating Lease, Liability, Current 223K USD +41.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 151K USD +58%
Lessee, Operating Lease, Liability, to be Paid, Year One 243K USD +54.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +42.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29.2K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 43.9K USD +88.5%
Deferred Tax Assets, Operating Loss Carryforwards 5.9M USD +11.3%
Preferred Stock, Shares Authorized 50M shares
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 22.7M USD
Depreciation, Depletion and Amortization 3.37K USD -27.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 195K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares